Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
Zeting Yuan(Shanghai University of Traditional Chinese Medicine), Ke Xu(Shanghai University of Traditional Chinese Medicine)
Cited by 60
Related Papers
Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway
|Oncotarget|2017|221
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
|Scientific Reports|2017|159
Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin
|Oncology Reports|2017|62
miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma
|Oncotarget|2017|55
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
|International Journal of Nanomedicine|2018|41